Home | Current Issue | Past Issues | Search | CollectionsRSS | PDA Services | FAQ | SHCIM Online | Chinese Updated Sunday, October 22, 2017
 Services
Submit a manuscript
Subscribe
Individuals
Institutions
Response
Send response
Read responses
Reprint
Advance online publication
Sign up for e-alert
JCIM job opportunities
Contact JCIM
 Information For
Readers
Authors
Reviewers
Advertisers
 About JCIM
Journal description
Editorial policy
Privacy policy
Copy right
Editorial staff
 Language Polishing
Journal of Chinese Integrative Medicine: 2011; 9(5): 503-514
DOI: 10.3736/jcim20110507
A case study exploration of the value of acupuncture as an adjunct treatment for patients diagnosed with schizophrenia: results and future study design
1. Patricia Ronan (Health Wellbeing and the Family, Beckett House, Canterbury Christ Church University, Canterbury, Kent, UK E-mail: patricia.ronan@canterbury.ac.uk)
2. Nicola Robinson (Allied Health Sciences Department, Faculty of Health and Social Care, London South Bank University, London, UK )
3. Dominic Harbinson (Canterbury Complementary Health Clinic, Canterbury, Kent, UK )
4. Douglas MacInnes (Centre for Health and Social Care Research, Canterbury Christ Church University, Chatham Maritime, Kent, UK )

Objective: This study explored the effects of individualized acupuncture when used alongside routine care for patients diagnosed with schizophrenia in order to assess the possibility and nature of potential benefits for this patient group. This study used an exploratory case study approach that included both quantitative and qualitative research tools, in order to generate a hypothesis questioning the possible benefits of acupuncture and develop future study designs.
Methods: Eleven patients diagnosed with schizophrenia were given multiple validated quantitative and qualitative assessments before, during and after a 10-week acupuncture intervention. A range of qualitative and quantitative assessments were employed including review of acupuncture, general practitioner and mental health clinical case notes. Qualitative data were interrogated to explore the reliability of participants’ reports to researchers, their clinicians and their carers while acting as informants in the study.
Results: Eight out of eleven participants completed a course of acupuncture treatment and all eleven reported positive benefits as a result of acupuncture, including improvements in the symptoms of schizophrenia, side effects of medication, energy, motivation, sleep, addictions and other associated physical problems. However, participants’ reports to the researcher and the acupuncturists varied at times and were often inconsistent between treatments, with participants revealing more information to the team towards the end of the study.
Conclusion: The study indicates that patients diagnosed with schizophrenia would benefit from acupuncture treatment alongside conventional treatment. Triangulation of the data highlights some inconsistencies in reporting from participants, but also that this can be overcome through the use of mixed research methods. Comparison of data also shows that future studies would benefit from using a Positive and Negative Syndrome Scale, the Standards for Reporting Interventions in Controlled Trials of Acupuncture and an enhanced questionnaire regarding side effects of medication, exercise, sleep and daily routine. It is also worth noting that future studies of this nature must maintain consideration for the vulnerability of participants as they recover and make support easily accessible.

Welcome to JCIM! You are the number 17546 reader of this article!
Download Article:
[Full Text]      [PDF]      [Chinese]      [Previous]      [Next]      [This Issue]
Please cite this article as:
Ronan P, Robinson N, Harbinson D, MacInnes D. A case study exploration of the value of acupuncture as an adjunct treatment for patients diagnosed with schizophrenia: results and future study design. J Chin Integr Med / Zhong Xi Yi Jie He Xue Bao. 2011; 9(5): 503-514.
References:
1McGrath JJ. Myths and plain truths about schizophrenia epidemiology — the NAPE lecture 2004[J].Acta Psychiatr Scand, 2005, 111(1): 4-11.  .
2Sundquist K, Frank G, Sundquist J. Urbanisation and incidence of psychosis and depression: follow-up study of 4.4 million women and men in Sweden[J].Br J Psychiatry, 2004, 184: 293-298.  .
3Torrey EF, Mortensen PB, Pedersen CB, Wohlfahrt J, Melbye M. Risk factors and confounders in the geographical clustering of schizophrenia[J].Schizophr Res, 2001, 49(3): 295-299.  .
4Peen J, Dekker J.. Admission rate for schizophrenia in the Netherlands[J].Acta Psychiatr Scand, 1997, 96(4): 301-305.  .
5Lewis G, David A, Andréasson S, Allebeck P. Schizophrenia and city life[J].Lancet, 1992, 340(8812): 137-140.  .
6Lambert TJ, Velakoulis D, Pantelis C. Medical comorbidity in schizophrenia[J].Med J Aust, 2003, 178(Suppl): S67-S70.  .
7Pompili M, Amador XF, Girardi P, Harkavy-Friedman J, Harrow M, Kaplan K, Krausz M, Lester D, Meltzer HY, Modestin J, Montross LP, Bo Mortensen P, Munk-Jrgensen P, Nielsen J, Nordentoft M, Saarinen P, Zisook S, Wilson ST, Tatarelli R. Suicide risk in schizophrenia: learning from the past to change the future[J].Ann Gen Psychiatry, 2007, 6: 10.  .
8Dyer JG, McGuinness TM. Update on early intervention in schizophrenia[J].J Psychosoc Nurs Ment Health Serv, 2008, 46(6): 19-22.  .
9Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment[J].Health Technol Assess, 2006, 10(17): iii-iv, ix-xi, 1-165.  .
10Ross CA, Read J. Antipsychotic medication: myths and facts. In: Read J, Mosher LR, Bentall RP. Models of madness: psychological, social and biological approaches to schizophrenia[M]. Hove and New York: Brunner-Routledge, 2004. 101-114.  .
11Rampes H. Mental health and complementary therapies: a research perspective. In: Darnell P, Pinder M, Treacy K. Searching for evidence: complementary therapies research[M]. London: The Prince of Wales’s Foundation for Integrated Health, 2006.  .
12Harbinson D, Ronan P. Acupuncture in the treatment of psychosis: the case for further research[J].Eur J Orient Med, 2006, 5(2): 24-33.  .
13Ong CK, Banks B. Complementary and alternative medicine: the consumer perspective[M]. London: The Prince of Wales’s Foundation for Integrated Health, 2003.  .
14Perkins R, Farmer P, Litchfield P. Realising ambitions: better employment support for people with a mental health condition[M]. London: The Stationary Office, 2009.  .
15World Health Organization. International classification of diseases 10 (ICD-10). 1992.
16Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review[J].Arch Gen Psychiatry, 2005, 62(9): 975-983.  .
17Stahl SM. Essential psychopharmacology: the prescriber’s guide[M]. Cambridge: Cambridge University Press, 2005.  .
18Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials[J].Am J Psychiatry, 2001, 158(4): 518-526.  .
19Ellenbroek BA. The pharmacotherapy of schizophrenia, past, present, and possible future. In: Bosch P, van den Noort M. Schizophrenia, sleep and acupuncture[M]. Gottingen: Hogrefe & Huber Publishers, 2008. 35-57.  .
20Goff DC, Shader RI. Non-neurological side-effects of antipsychotic drugs. In: Hirsch SR, Weinberger DR. Schizophrenia[M]. 2nd ed. Oxford: Blackwell Publishing, 2003. 573-588.  .
21Joint Formulary Committee. British National Formulary. [online] 2011 ed. London: British Medical Association and Royal Pharmaceutical Society, 2011[2010-12-1]. http://bnf.org/bnf/index.htm.
22Lee MS, Shin BC, Ronan P, Ernst E. Acupuncture for schizophrenia: a systematic review and meta-analysis[J].Int J Clin Pract, 2009, 63(11): 1622-1633.  .
23Rathbone J, Xia J. Acupuncture for schizophrenia[J].Cochrane Database Syst Rev, 2005, (4): CD005475.  .
24Bosch P, van den Noort M. The search for the mechanism behind acupuncture: research with neuroimaging. In: Bosch P, van den Noort M. Schizophrenia, sleep and acupuncture[M]. Gottingen: Hogrefe & Huber Publishers, 2008. 175-201.  .
25Pegram A. What is case study research?[J].Nurse Res, 1999, 7(2): 5-16.  .
26Vallis J, Tierney A. Issues in case study analysis[J].Nurse Res, 1999, 7(2): 19-35.  .
27Platt J. “Case study” in American methodological thought[J].Curr Sociol, 1992, 40(1): 17-48.  .
28Stoecker R. Evaluating and rethinking the case study[J].Sociol Rev, 1991, 39(1): 88-112.  .
29Sandelowski M. One is the liveliest number: the case orientation of qualitative research[J].Res Nurs Health, 1996, 19(6): 525-529.  .
30Yin RK. Case study research: design and methods[M]. 3rd ed. Thousand Oaks: Sage Publications, 2003.  .
31Bergen A, While A. A case for case studies: exploring the use of case study design in community nursing research[J].J Adv Nurs, 2000, 31(4): 926-934.  .
32Hamel J, Dufour S, Fortin D. Case study methods[M]. Newbury Park: Sage Publications, 1993.  .
33Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M; Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance[J].BMJ, 2008, 337: a1655.  .
34Medical Research Council. A Framework for development and evaluation of RCTs for complex interventions to improve health. 2000; Apr 01.
35Jones C, Lyons C. Case study: design? Method? Or comprehensive strategy?[J].Nurse Res, 2004, 11(3): 70-76.  .
36Stake RE. The art of case study research[M]. Thousand Oaks: Sage Publications, 1995.  .
37Kay SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale (PANSS)[M]. 2nd ed. New York: Multi-Health Systems, Inc, 2000.  .
38Kay SR, Opler LA, Lindenmayer JP. The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation[J].Br J Psychiatry Suppl, 1989, (7): 59-67.  .
39Martin CR, Allan R. Factor structure of the Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4)[J].Psychol Health Med, 2007, 12(2): 126-134.  .
40Wilkinson G, Hesdon B, Wild D, Cookson R, Farina C, Sharma V, Fitzpatrick R, Jenkinson C. Self-report quality of life measure for people with schizophrenia: the SQLS[J].Br J Psychiatry, 2000, 177: 42-46.  .
41Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research[J].Psychiatry Res, 1989, 28(2): 193-213.  .
42Watson H, Whyte R. Using observation. In: Gerrish K, Lacey A. The research process in nursing[M]. 5th ed. Oxford: Blackwell Publishing, 2006. 383-398.  .
43MacPherson H, White A, Cummings M, Jobst K, Rose K, Niemtzow R, for the STRICTA Group. Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendations[J].Clin Acupunct Orient Med, 2002, 3(1): 6-9.  .
44MacPherson H, White A, Cummings M, Jobst K, Rose K, Niemtzow R. Standards for reporting interventions in controlled trials of acupuncture: the STRICTA recommendations[J].Complement Ther Med, 2001, 9(4): 246-249.  .
45Bosch P, Ronan P, Quinton N, Harbinson D, van den Noort M. Acupuncture and schizophrenia: first European studies — initial results. ICCMR 2010: 5th International Congress on Complementary Medicine Research. Troms?: May 19-21, 2010.
46Ronan P, Bosch P. Breaking new ground: designing a methodology to investigate a complex intervention for a complex condition. ICCMR 2010: 5th International Congress on Complementary Medicine Research. Troms?: May 19-21, 2010.
47Ronan P, Robinson N, Harbinson D, MacInnes D. Acupuncture and schizophrenia: choices for collecting evidence: limitations and significance[J].Eur J Orient Med, 2010, 6(5): 15-31.  .
48Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences[J].Behav Res Methods, 2007, 39(2): 175-191.  .
49Grandner MA, Kripke DF, Yoon YI, Youngstedt SD. Criterion validity of the Pittsburgh Sleep Quality Index: Investigation in a non-clinical sample[J].Sleep Biol Rhythm, 2006, 4(2): 129-136.  .
50Carpenter JS, Andrykowski MA. Psychometric evaluation of the Pittsburgh Sleep Quality Index[J].J Psychosom Res, 1998, 5(1 Spec No): 5-13.  .
51Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET. Meta-analysis of regional brain volumes in schizophrenia[J].Am J Psychiatry, 2000, 157(1): 16-25.  .
52Camm AJ. Cardiovascular risk associated with schizophrenia and its treatment[M]. London: Galliard Healthcare Communications, 2003.  .
53Parahoo K. Nursing research: principles, process and issues[M]. 2nd ed. Basingstoke: Palgrave Macmillan, 2006.  .
54Cresswell JW. Qualitative inquiry and research design: choosing among five approaches[M]. 2nd ed. Thousand Oaks: Sage Publications, Inc, 2007.  .
55Yin RK. Applications of case study research[M]. Newbury Park: Sage Publications, Inc, 1993.  .
56Gentili A, Weiner DK, Kuchibhatla M, Edinger JD. Test-retest reliability of the Pittsburgh sleep quality index in nursing home residents[J].J Am Geriatr Soc, 1995, 43(11): 1317-1318.  .

 Home | Current Issue | Past Issues | Search | CollectionsRSS | PDA Services | FAQ | SHCIM Online | Chinese
Copyright © 2003-2012 by JCIM Press. All rights reserved. ISSN 1672-1977